Cargando…
Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392354/ https://www.ncbi.nlm.nih.gov/pubmed/28407701 http://dx.doi.org/10.18632/oncotarget.16155 |
_version_ | 1783229435038662656 |
---|---|
author | Viúdez, Antonio Carvalho, Filipe L.F. Maleki, Zahra Zahurak, Marianna Laheru, Daniel Stark, Alejandro Azad, Nilofer S. Wolfgang, Christopher L. Baylin, Stephen Herman, James G. De Jesus-Acosta, Ana |
author_facet | Viúdez, Antonio Carvalho, Filipe L.F. Maleki, Zahra Zahurak, Marianna Laheru, Daniel Stark, Alejandro Azad, Nilofer S. Wolfgang, Christopher L. Baylin, Stephen Herman, James G. De Jesus-Acosta, Ana |
author_sort | Viúdez, Antonio |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5392354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53923542017-04-21 Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET) Viúdez, Antonio Carvalho, Filipe L.F. Maleki, Zahra Zahurak, Marianna Laheru, Daniel Stark, Alejandro Azad, Nilofer S. Wolfgang, Christopher L. Baylin, Stephen Herman, James G. De Jesus-Acosta, Ana Oncotarget Correction Impact Journals LLC 2017-03-13 /pmc/articles/PMC5392354/ /pubmed/28407701 http://dx.doi.org/10.18632/oncotarget.16155 Text en Copyright: © 2017 Viúdez et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Viúdez, Antonio Carvalho, Filipe L.F. Maleki, Zahra Zahurak, Marianna Laheru, Daniel Stark, Alejandro Azad, Nilofer S. Wolfgang, Christopher L. Baylin, Stephen Herman, James G. De Jesus-Acosta, Ana Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET) |
title | Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET) |
title_full | Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET) |
title_fullStr | Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET) |
title_full_unstemmed | Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET) |
title_short | Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET) |
title_sort | correction: a new immunohistochemistry prognostic score (ips) for recurrence and survival in resected pancreatic neuroendocrine tumors (pannet) |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392354/ https://www.ncbi.nlm.nih.gov/pubmed/28407701 http://dx.doi.org/10.18632/oncotarget.16155 |
work_keys_str_mv | AT viudezantonio correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT carvalhofilipelf correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT malekizahra correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT zahurakmarianna correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT laherudaniel correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT starkalejandro correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT azadnilofers correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT wolfgangchristopherl correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT baylinstephen correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT hermanjamesg correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet AT dejesusacostaana correctionanewimmunohistochemistryprognosticscoreipsforrecurrenceandsurvivalinresectedpancreaticneuroendocrinetumorspannet |